{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:02:39Z","timestamp":1790686959259,"version":"4.1.0"},"reference-count":31,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Noonan syndrome (NS) is characterized by marked phenotypic variability. Although the classical phenotype includes short stature, craniofacial dysmorphism, skeletal abnormalities, and congenital heart defects, some patients present with subtle or atypical manifestations, making clinical recognition challenging. Methods: This retrospective case series included six pediatric patients with molecularly confirmed NS managed at the Department of Endocrinology and Metabolic Diseases, Polish Mother\u2019s Memorial Hospital-Research Institute, Lodz, Poland. Medical records were reviewed for auxological data, phenotypic features, endocrine and skeletal assessment, cardiovascular findings, associated conditions, and multidisciplinary management. The aim of this study was to characterize the phenotypic diversity of NS in pediatric endocrine practice, with particular emphasis on growth patterns, endocrine and skeletal manifestations, and atypical clinical presentations. Results: The six patients demonstrated markedly heterogeneous clinical presentations. One boy exhibited the classical phenotype with severe short stature and pulmonary valve stenosis, whereas a girl with typical NS features maintained relatively preserved growth around the 3rd percentile. Another patient presented with progressive resorption of permanent incisor roots and a coexisting pathogenic NBN variant. A boy with LZTR1-associated NS and Klinefelter syndrome (47,XXY) demonstrated a blended phenotype and height between the 25th and 50th percentiles. Two girls lacked characteristic NS dysmorphism and presented predominantly with growth impairment, accompanied by markedly low bone mass in one case and a prolonged diagnostic pathway in the other. GH deficiency was not identified in the evaluated patients, and rhGH therapy was initiated in three patients. Conclusions: NS encompasses a broad clinical spectrum, ranging from classical phenotypes to atypical presentations dominated by growth, skeletal, or dental abnormalities. Neither the absence of characteristic dysmorphism nor relatively preserved growth excludes the diagnosis, while coexisting genetic conditions may further modify the phenotype. Awareness of this heterogeneity is essential for appropriate recognition and individualized multidisciplinary care. In selected children with otherwise unexplained growth or atypical clinical findings, consideration of NS and genetic evaluation may help establish a unifying diagnosis and potentially shorten the diagnostic pathway.<\/jats:p>","DOI":"10.3390\/jcm15197561","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:09:25Z","timestamp":1790683765000},"page":"7561","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Diverse Clinical Spectrum of Noonan Syndrome in Pediatric Endocrinology: From Classical to Atypical Phenotypes"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9168-0192","authenticated-orcid":false,"given":"Sara","family":"Aszkie\u0142owicz","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolic Diseases, Polish Mother\u2019s Memorial Hospital\u2014Research Institute of Lodz, 93-338 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6697-5877","authenticated-orcid":false,"given":"Anna","family":"\u0141upi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolic Diseases, Polish Mother\u2019s Memorial Hospital\u2014Research Institute of Lodz, 93-338 Lodz, Poland"},{"name":"Department of Developmental Age and Adult Endocrinology, Medical University of Lodz, 93-338 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2941-8868","authenticated-orcid":false,"given":"Arkadiusz","family":"Zygmunt","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolic Diseases, Polish Mother\u2019s Memorial Hospital\u2014Research Institute of Lodz, 93-338 Lodz, Poland"},{"name":"Department of Developmental Age and Adult Endocrinology, Medical University of Lodz, 93-338 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0508-2186","authenticated-orcid":false,"given":"Renata","family":"Stawerska","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolic Diseases, Polish Mother\u2019s Memorial Hospital\u2014Research Institute of Lodz, 93-338 Lodz, Poland"},{"name":"Department of Developmental Age and Adult Endocrinology, Medical University of Lodz, 93-338 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"project-administration","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Stagi, S., Ferrari, V., Ferrari, M., Priolo, M., and Tartaglia, M. (2022). Inside the Noonan \u201cUniverse\u201d: Literature Review on Growth, GH\/IGF Axis and rhGH Treatment: Facts and Concerns. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.951331"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1542\/peds.2009-3207","article-title":"Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines","volume":"126","author":"Romano","year":"2010","journal-title":"Pediatrics"},{"key":"ref_3","first-page":"468","article-title":"Associated Noncardiac Malformations in Children with Congenital Heart Disease","volume":"63","author":"Noonan","year":"1963","journal-title":"Midwest Soc. Pediatr. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.joim.2024.04.001","article-title":"A review of whole-medical systems and holistic care approach for type 2 diabetes and associated metabolic syndrome","volume":"22","author":"Makoni","year":"2024","journal-title":"J. Integr. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/340847","article-title":"PTPN11 Mutations in Noonan Syndrome: Molecular Spectrum, Genotype-Phenotype Correlation, and Phenotypic Heterogeneity","volume":"70","author":"Tartaglia","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Dahlgren, J., and Noordam, C. (2022). Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome. J. Clin. Med., 11.","DOI":"10.3390\/jcm11072034"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41418-019-0395-5","article-title":"LZTR1 Facilitates Polyubiquitination and Degradation of RAS-GTPases","volume":"27","author":"Abe","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/cge.13533","article-title":"Delineation of Dominant and Recessive Forms of LZTR1-Associated Noonan Syndrome","volume":"95","author":"Pagnamenta","year":"2019","journal-title":"Clin. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/hmg\/ddy412","article-title":"Dominant Noonan Syndrome-Causing LZTR1 Mutations Specifically Affect the Kelch Domain Substrate-Recognition Surface and Enhance RAS-MAPK Signaling","volume":"28","author":"Motta","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1651-2227.2005.tb02081.x","article-title":"Improved Final Height with Long-Term Growth Hormone Treatment in Noonan Syndrome","volume":"94","author":"Osio","year":"2005","journal-title":"Acta Paediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1210\/jc.2005-0995","article-title":"PTPN11 Mutations Are Associated with Mild Growth Hormone Resistance in Individuals with Noonan Syndrome","volume":"90","author":"Binder","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_12","first-page":"18","article-title":"Somatic development indices in children and youth of Warsaw","volume":"5","author":"Palczewska","year":"2001","journal-title":"Med. Wieku Rozw."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1210\/jc.2011-1111","article-title":"Revised Reference Curves for Bone Mineral Content and Areal Bone Mineral Density According to Age and Sex for Black and Non-Black Children: Results of the Bone Mineral Density in Childhood Study","volume":"96","author":"Zemel","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.21037\/tp-2025-422","article-title":"Noonan Syndrome with PTPN11 Gene Variant Presenting as Isolated Short Stature: A Case Report","volume":"14","author":"Peng","year":"2025","journal-title":"Transl. Pediatr."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Han, J.Y., and Park, J. (2024). Paternally Inherited Noonan Syndrome Caused by a PTPN11 Variant May Exhibit Mild Symptoms: A Case Report and Literature Review. Genes, 15.","DOI":"10.3390\/genes15040445"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ymgme.2012.04.003","article-title":"Decreased Bone Mineralization in Children with Noonan Syndrome: Another Consequence of Dysregulated RAS MAPKinase Pathway?","volume":"106","author":"Choudhry","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40618-016-0541-6","article-title":"Klinefelter Syndrome (KS): Genetics, Clinical Phenotype and Hypogonadism","volume":"40","author":"Bonomi","year":"2017","journal-title":"J. Endocrinol. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ajmg.1320270330","article-title":"Noonan and Klinefelter Syndromes in a Child","volume":"27","author":"Verloes","year":"1987","journal-title":"Am. J. Med. Genet."},{"key":"ref_19","first-page":"1175","article-title":"Autosomal Recessive Noonan Syndrome Associated with Biallelic LZTR1 Variants","volume":"20","author":"Johnston","year":"2018","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"ref_20","first-page":"1503","article-title":"Oral Manifestations of Noonan Syndrome: Review of the Literature and a Report of Four Cases","volume":"55","author":"Mallineni","year":"2014","journal-title":"Rom. J. Morphol. Embryol. Rev. Roum. Morphol. Embryol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/ocr.12144","article-title":"A review of craniofacial and dental findings of the RASopathies","volume":"20","author":"Cao","year":"2017","journal-title":"Orthod. Craniofacial Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15644\/asc56\/1\/9","article-title":"Giant Cell Lesions of the Jaws Involving RASopathy Syndromes","volume":"56","author":"Luna","year":"2022","journal-title":"Acta Stomatol. Croat."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ejhg.2009.44","article-title":"SOS1 and PTPN11 Mutations in Five Cases of Noonan Syndrome with Multiple Giant Cell Lesions","volume":"17","author":"Beneteau","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.21873\/invivo.12797","article-title":"Sequential Loss of Mandibular Permanent Incisors in Noonan Syndrome","volume":"36","author":"Friedrich","year":"2022","journal-title":"In Vivo"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/iej.13715","article-title":"Present status and future directions: Root resorption","volume":"55","author":"Patel","year":"2022","journal-title":"Int. Endod. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/0022034516677539","article-title":"Cellular and Molecular Pathways Leading to External Root Resorption","volume":"96","author":"Hartsfield","year":"2017","journal-title":"J. Dent. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12105-010-0178-2","article-title":"Giant Cell Lesions in Noonan Syndrome: Case Report and Review of The Literature","volume":"4","author":"Bufalino","year":"2010","journal-title":"Head Neck Pathol."},{"key":"ref_28","first-page":"e26","article-title":"Oral Health and Dental Management Strategies in Noonan Syndrome: A Case Report","volume":"20","author":"Esmaeelpour","year":"2025","journal-title":"Iran. Endod. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ejhg.2011.37","article-title":"Cancer Risk in Patients with Noonan Syndrome Carrying a PTPN11 Mutation","volume":"19","author":"Jongmans","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_30","first-page":"370","article-title":"Noonan Syndrome, Cancer Risk, and Growth Hormone Treatment","volume":"17","author":"Demir","year":"2025","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"ref_31","first-page":"889","article-title":"Growth Hormone Treatment in Children with Noonan\u2019s Syndrome: Four Year Results of a Partly Controlled Trial","volume":"90","author":"Noordam","year":"2001","journal-title":"Acta Paediatr."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7561\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:46:17Z","timestamp":1790685977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":31,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197561"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197561","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]}}}